CLINICAL_TRIALS
trial_result
· 2019-12-24
Clinical Trial Update: A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS) [Phase 1, Phase 2]
Summary
A pilot Phase 1/2 trial evaluating triheptanoin in people with amyotrophic lateral sclerosis (ALS) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Richard Bedlack, M.D., Ph.D. | Conditions: ALS | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-12-24